For example, high expression of GCLM induces the emergence of breast cancer treatment resistance34; GCLC is highly expressed in lung cancer and melanoma35; and GSS mutations are associated with recurrence of small cell lung and bladder cancer36. Here, GCLC is linked to breast cancer.